Evidence map›Paper›PMID 40377797›Full record

ArticleJournal of fluorescence2025

Innovative Design of Sustainable On-Off Fluorescence-Mode Technique for Facile Measurement of Brexpiprazole, a New Antipsychotic Therapy in Different Matrices; Content Uniformity Evaluation; Comprehensive Sustainability Profiling.

Badriah Saad Al-Farhan, Ahmed Abdulhafez Hamad

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of fluorescence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Badriah Saad Al-FarhanChemistry Department, Faculty of Science, King Khalid University, Abha, 61421, Saudi Arabia.
Ahmed Abdulhafez HamadDepartment of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut Branch, Al-Azhar University, Assiut, 71524, Egypt. ahmedabdelhafez@azhar.edu.eg.ORCID http://orcid.org/0000-0002-7088-0723

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, a new antipsychotic treatment called brexpiprazole (BPZ) has been used to treat schizophrenia and other forms of psychosis. A straightforward, sensitive, precise, and environmentally friendly spectrofluorimetric technique was developed to measure it by forming an ion-pair association complex with Eosin Y. The dye's intrinsic fluorescence recorded at λ

Indexed as

Antipsychotic AgentsQuinolonesThiophenesFluorescenceFluorescent DyesLimit of DetectionSpectrometry, FluorescenceAntipsychotic AgentsbrexpiprazoleFluorescent DyesQuinolonesThiophenesBrexpiprazoleContent homogeneityMethod's sustainability profileOn-off fluorescence strategy

Identifiers

PMID40377797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.